GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

Risk Factors of Hepatocellular Carcinoma - Current Status and Perspectives

(2012) Jing Gao et al.   Asian Pacific Journal of Cancer Prevention

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

(2012) Hashem B. El-Serag   GASTROENTEROLOGY

First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study

(2012) R. Lencioni et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Épidémiologie, histoire naturelle et pathogenèse du carcinome hépatocellulaire

(2011) E. Maillard   Cancer Radiotherapie

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

(2011) Massimo Iavarone et al.   HEPATOLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib

(2010) Violaine Ozenne et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study

(2010) R. Lencioni et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

(2009) Puneeta Tandon et al.   LIVER INTERNATIONAL

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE